Work

PTK787/ZK 222584 (PTK/ZK), an Oral Tyrosine Kinase Inhibitor, Has Activity in Patients with Agnogenic Myeloid Metaplasia (AMM).

Year: 2006

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v108.11.4920.4920

Authors: Francis J. Giles, Michael Carroll, Alan List, Alessandra Ferrajoli, Deborah Thomas, Jorge Cortes, Eric Feldman, Gail Roboz

Institutions: The University of Texas MD Anderson Cancer Center, NewYork–Presbyterian Hospital, Cornell University

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2520564807

FWCI:

Cites:

Cited by:

Related to: 10